`Literature Review and Commentary
By Alan R. Gaby, MD
Cow’s Milk As a Cause of Constipation in Children …
Sixty-nine children (mean age, 5 years; range, 6 months to 14 years) with chronic constipation eliminated cow’s milk from their diet for 3 weeks. Twenty-seven children experienced a resolution of constipation after 1 to 5 days, a return of constipation within 2 to 5 days after reintroduction of 500 ml per day of cow’s milk, and another resolution of constipation after milk was again withdrawn. Another 8 children experienced a slow improvement over a period of 1 to 3 weeks during cow’s milk avoidance, and did not suffer an exacerbation when 500 ml per day of cow’s milk was reintroduced for 3 weeks. Thus, a total of 51% of the children showed a positive response to cow’s milk avoidance. There was no difference between responders and nonresponders with respect to serum IgE antibodies to cow’s milk proteins, suggesting that milk-induced constipation is not mediated by IgE.
Comment
: Chronic constipation is a common problem among children. The results of the present study suggest that sensitivity to cow’s milk is a major contributing factor in more than half of children who suffer from chronic constipation. The study confirms at least 5 other reports implicating cow’s milk as a frequent cause of childhood constipation. A trial of cow’s milk avoidance should therefore be considered for all children with chronic constipation.
Irastorza I et al. Cow’s-milk-free diet as a therapeutic option in childhood chronic constipation. J Pediatr Gastroenterol Nutr. 2010;51:171–176.
…
Also Consider Probiotic Therapy
Forty-four infants at least 6 months of age (mean, 8 months) with functional chronic constipation were randomly assigned to receive, in double-blind fashion, Lactobacillus reuteri (DSM 17938) at a dose of 108 colony-forming units once a day or placebo for 8 weeks. The frequency of bowel movements was significantly higher in the active-treatment group than in the placebo group at week 2 (p < 0.05), week 4 (p < 0.01), and week 8 (p < 0.03). No adverse effects were reported.
Comment
: This study indicates that the probiotic strain Lactobacillus reuteri (DSM 17938) increased the frequency of bowel movements in infants with functional chronic constipation. While the mechanism of action is not known, the treatment may have worked by altering the intestinal flora or by improving digestion. Probiotic therapy should be considered for children with constipation who do not respond to basic measures such as avoiding cow’s milk and consuming adequate amounts of fiber and fluids.
Coccorullo P et al. Lactobacillus reuteri (DSM 17938) in infants with functional chronic constipation: a double-blind, randomized, placebo-controlled study. J Pediatr. 2010;157:598–602.
B Vitamins, Homocysteine, and Brain Atrophy
Two hundred seventy-one elderly individuals (mean age, 77 years) with mild cognitive impairment were randomly assigned to receive, in double-blind fashion, placebo or B vitamins (0.8 mg of folic acid, 0.5 mg of vitamin B12, and 20 mg of vitamin B6) daily for 2 years. One hundred sixty-eight participants completed the trial. The mean rate of brain atrophy per year (as determined by MRI scans) was 29.6% lower in the active-treatment group than in the placebo group (0.76% vs, 1.08%; p = 0.001). The treatment response was related to baseline homocysteine levels: the rate of atrophy in participants with a homocysteine level > 13 µmol/L (the highest quartile) was 53% lower in the active-treatment group than in the placebo group (p = 0.001). In contrast, active treatment had no effect in participants with a baseline homocysteine level ≤ 9.5 µmol/L (the lowest quartile). A greater rate of atrophy was associated with lower final scores on tests of cognitive.
Comment
: About 1 of every 6 people over age 70 has mild cognitive impairment, and half of individuals with mild cognitive impairment develop Alzheimer’s disease. Accelerated brain atrophy has been observed in people with mild cognitive impairment who progress to Alzheimer’s disease. An elevated homocysteine level is a risk factor for brain atrophy, cognitive impairment, and dementia; and treatment with folic acid, vitamin B12, and vitamin B6 is known to decrease homocysteine levels. The results of the present study indicate that the rapid rate of brain atrophy in elderly individuals with mild cognitive impairment can be slowed by treatment with homocysteine-lowering B vitamins.
Smith AD et al. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLoS One. 2010;5(9):e12244.
Pediatric Cancer Patients Are Deficient in Calcium and Vitamin D
Fifty-two children (mean age, 12 years) who had been treated for solid cancers and were in remission were evaluated. Of these children, 21 were again evaluated 1 year after the completion of treatment. Calcium intake was inadequate in 75% of the patients. The serum 25-hydroxyvitamin D concentration was < 20 ng/ml (low to borderline-low) in 61.5% of patients and < 10 ng/ml (frankly deficient) in 11.5%. Bone mineral density was low at the spine in 32.7% of patients and at the femur in 24% of patients. Fractures were seen in 10 patients, but were not correlated with bone mineral density.
Comment
: This study indicates that calcium intake and vitamin D status are inadequate in a high proportion of pediatric cancer survivors, and that these patients often have low bone mass and/or fractures. Nutritional status should be assessed in children with a history of cancer, and appropriate dietary modifications and nutritional supplements should be recommended. Nutrients besides calcium and vitamin D that enhance bone health include magnesium, vitamin K, B vitamins, and trace minerals (zinc, copper, manganese, silicon, boron, and strontium).
Bilariki K et al. Low bone mineral density and high incidences of fractures and vitamin D deficiency in 52 pediatric cancer survivors. Horm Res Paediatr. 2010;74:319–327.
Almonds Improve Heart Disease Risk Factors
Sixty-five individuals (mean age, 54 years) with prediabetes were randomly assigned to consume an American Diabetes Association (ADA) diet without nuts (control diet) or an ADA diet containing 20% of energy from almonds (approximately 2 ounces per day) for 16 weeks. Compared with the control diet, the almond diet resulted in a significant improvement in insulin resistance. The mean LDL-cholesterol level fell to a greater extent with the almond diet than with the control diet (−12.4 vs. −0.4 mg/dl; p = 0.052). No changes were seen in body mass index or blood pressure.
Comment
: Numerous observational studies have found that increasing consumption of nuts is associated with a decreasing incidence of cardiovascular disease. The results of the present study suggest that the mechanisms by which nut consumption might prevent heart disease include an improvement in insulin resistance and a reduction in LDL-cholesterol levels. In addition, nuts contain a wide range of cardioprotective nutrients, including magnesium, essential fatty acids, and fiber.
Wien M et al. Almond consumption and cardiovascular risk factors in adults with prediabetes. J Am Coll Nutr. 2010;29:189–197.
Dark Chocolate and Blood Pressure: Low Doses Are Effective
One hundred two patients (mean age, 66 years) with prehypertension/stage 1 hypertension and cardiovascular end-organ damage or diabetes were randomly assigned to consume 6 g per day or 25 g per day of flavanol-rich dark chocolate for 3 months. Significant reductions in mean ambulatory 24-hour blood pressure were seen in both groups (6 g per day: −2.3 mm Hg; 25 g per day: 1.9 mm Hg), with no significant difference between groups.
Comment
: Previous studies have shown that consumption of flavonol-rich dark chocolate can lower blood pressure, whereas white chocolate (which is low in flavonols) had no effect. The results of the present study suggest that an antihypertensive effect of dark chocolate can be achieved with a relatively small dose (less than one-quarter of an ounce per day), and that higher amounts may not provide any additional benefit. Although large amounts of chocolate can contribute to obesity and may have potentially deleterious psychoactive effects, a dosage of 6 g per day is not likely to cause adverse effects in most people.
Desch S et al. Low vs. higher-dose dark chocolate and blood pressure in cardiovascular high-risk patients. Am J Hypertens. 2010;23:694–700.
Cherry Juice for Gout: Reviving an Old Remedy
According to a report in Family Practice News, Dr. Naomi Schlesinger (chief of the Division of Rheumatology and Connective Tissue Research at Robert Wood Johnson Medical School, New Brunswick, New Jersey) administered 1 tablespoon of Brownswood Acres tart cherry juice concentrate twice a day for an unspecified period of time to more than 100 patients with a history of gout. Ninety-two percent of the patients experienced a 50%-or-greater reduction in the number of acute gout attacks. Cherry juice did not lower serum uric acid levels.
Comment
: In 1950, Dr. L. W. Blau reported that consumption of one-half pound per day of fresh or canned cherries (or an equivalent amount of cherry juice) prevented gout attacks in patients with a history of gout. While this observation was ignored by the conventional medical community, cherry juice is widely used as a folk remedy for gout. It is encouraging that a rheumatologist has revived this old treatment and reported her findings. Preliminary evidence suggests that cherries contain flavonoids that have an anti-inflammatory effect.
Jancin B. Cherry juice flowing in gout treatment pipeline. Fam Pract News. 2010(September 1):38.
Vitamin C Prevents Postoperative Arrhythmia
One hundred seventy patients (mean age, 72 years) scheduled to undergo elective isolated on-pump coronary artery bypass grafting were randomly assigned to receive vitamin C intravenously or placebo. The dosage was 2 g given 3 hours prior to the initiation of the cardiopulmonary bypass, followed by 500 mg twice a day for 5 days. The incidence of postoperative atrial fibrillation was significantly lower in the vitamin C group than in the placebo group (44.7% vs. 61.2%; p = 0.04). Mean time to conversion of atrial fibrillation to sinus rhythm (5 vs. 7.3 hours; p < 0.05), mean length of stay in intensive care (1.6 vs. 2.1 days; p = 0.05), and mean length of hospital stay (7.9 vs. 9.8 days; p = 0.04) were significantly shorter in the vitamin C group than in the placebo group.
Comment
: Postoperative atrial fibrillation occurs frequently in patients undergoing cardiac surgery. Although it is usually self-limited, it is associated with increased 1-month and 6-month mortality rates and other adverse outcomes. Oxidative stress appears to play a role in the pathogenesis of postoperative atrial fibrillation. The results of the present study indicate that perioperative administration of vitamin C to patients undergoing coronary artery bypass grafting prevented postoperative atrial fibrillation and shortened the time in intensive care and in the hospital.
Papoulidis P et al. The role of ascorbic acid in the prevention of atrial fibrillation after elective on pump myocardial revascularization surgery: a single center experience-pilot study. Interact Cardiovasc Thorac Surg. 2011;12:121–124.









0 Comments